(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | |||||||||
Earning before tax | ---- | 15.12%25.45B | 15.22%40.28B | ---- | 17.38%22.11B | 3.62%34.96B | --18.83B | 6.58%33.74B | --31.66B |
Profit adjustment | |||||||||
Interest (income) - adjustment | ---- | -6.28%-3.04B | -17.63%-5.98B | ---- | -15.68%-2.86B | -6.30%-5.08B | ---2.47B | -45.23%-4.78B | ---3.29B |
Attributable subsidiary (profit) loss | ---- | -23.93%-431.94M | -11.92%-680.76M | ---- | -32.52%-348.55M | -8.49%-608.28M | ---263.01M | -39.29%-560.68M | ---402.53M |
Impairment and provisions: | ---- | -10.44%367.64M | -39.03%638.4M | ---- | -3.09%410.48M | 20.78%1.05B | --423.57M | -9.02%866.87M | --952.81M |
-Impairmen of inventory (reversal) | ---- | 73.80%332.44M | -19.76%403.4M | ---- | -7.62%191.27M | 4.23%502.76M | --207.06M | -26.14%482.37M | --653.06M |
-Other impairments and provisions | ---- | -83.94%35.21M | -56.82%235M | ---- | 1.25%219.21M | 41.56%544.29M | --216.51M | 28.27%384.5M | --299.76M |
Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | --370.52M | ---- | ---3.78B |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | --370.52M | ---- | ---3.78B |
Asset sale loss (gain): | ---- | -1,237.33%-114.01M | 1.69%60.87M | ---- | ---8.53M | 202.74%59.85M | ---- | ---58.26M | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -1,237.33%-114.01M | 1.69%60.87M | ---- | ---8.53M | 202.74%59.85M | ---- | ---58.26M | ---- |
Depreciation and amortization: | ---- | 16.24%3.84B | 12.93%7.35B | ---- | 1.42%3.3B | 0.22%6.51B | --3.25B | 10.14%6.49B | --5.89B |
-Depreciation | ---- | 16.24%3.84B | 12.93%7.35B | ---- | --3.3B | 0.22%6.51B | ---- | --6.49B | ---- |
-Other depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | --3.25B | ---- | --5.89B |
Financial expense | ---- | -89.62%168.79M | 106.23%2.29B | ---- | 250.73%1.63B | 23.52%1.11B | --463.59M | -10.69%898.06M | --1.01B |
Exchange Loss (gain) | ---- | 303.47%262.01M | 105.98%17.25M | ---- | 11.67%-128.77M | -159.46%-288.49M | ---145.79M | 26.55%485.22M | --383.41M |
Special items | ---- | -28.84%443.38M | 1.50%1.71B | ---- | -26.74%623.09M | 2,876.56%1.68B | --850.52M | -105.03%-60.52M | --1.2B |
Operating profit before the change of operating capital | ---- | 8.99%26.94B | 15.99%45.68B | ---- | 15.98%24.72B | 6.38%39.38B | --21.31B | 10.12%37.02B | --33.62B |
Change of operating capital | |||||||||
Inventory (increase) decrease | ---- | -52.79%6.7B | 148.61%206.06M | ---- | 66.24%14.2B | 97.21%-423.93M | --8.54B | -743.11%-15.2B | ---1.8B |
Accounts receivable (increase)decrease | ---- | -65.88%-19.76B | 20.99%-8.01B | ---- | 29.42%-11.91B | -892.12%-10.14B | ---16.88B | 90.60%-1.02B | ---10.88B |
Accounts payable increase (decrease) | ---- | 164.10%27.6B | 262.91%16.16B | ---- | 291.40%10.45B | -69.32%4.45B | --2.67B | -35.03%14.52B | --22.35B |
Special items for working capital changes | ---- | 10.76%-3.38B | 28.48%10.52B | ---- | -138.72%-3.79B | 56.40%8.19B | --9.78B | 168.16%5.23B | ---7.68B |
Cash from business operations | ---- | 13.17%38.1B | 55.71%64.55B | ---- | 32.42%33.67B | 2.24%41.46B | --25.42B | 13.88%40.55B | --35.61B |
Other taxs | ---- | -22.16%-5.25B | -0.91%-7.62B | ---- | 0.41%-4.3B | -37.34%-7.55B | ---4.32B | -2.55%-5.5B | ---5.36B |
Interest received - operating | ---- | 53.66%641.82M | 28.83%974.38M | ---- | 44.37%417.7M | 88.38%756.34M | --289.34M | 8.04%401.5M | --371.63M |
Adjustment items of business operations | 34.56%60.26B | ---- | ---- | --44.79B | ---- | ---- | ---- | ---- | ---- |
Net cash from operations | 34.56%60.26B | 12.43%33.49B | 67.07%57.9B | --44.79B | 39.22%29.78B | -2.23%34.66B | --21.39B | 15.79%35.45B | --30.61B |
Cash flow from investment activities | |||||||||
Interest received - investment | ---- | -49.43%1.55B | 44.18%4.98B | ---- | 11.88%3.07B | -35.64%3.45B | --2.74B | 16.31%5.36B | --4.61B |
Dividend received - investment | -32.54%2.86B | 60.91%580.48M | 3.28%360.75M | --4.23B | 27.53%360.75M | 21.85%349.29M | --282.89M | 8.13%286.67M | --265.12M |
Sale of fixed assets | 402.15%601M | 238.36%382.4M | 63.59%391.36M | --119.69M | 75.13%113.02M | -28.84%239.23M | --64.53M | 22.90%336.19M | --273.54M |
Purchase of fixed assets | -21.62%-5.04B | -33.63%-3.73B | 14.12%-6.31B | ---4.14B | 2.59%-2.79B | -7.72%-7.35B | ---2.87B | -46.57%-6.83B | ---4.66B |
Sale of subsidiaries | 574.22%40.45M | -183.67%-189.76M | -19.02%14.56M | --6M | -551.09%-66.89M | -92.05%17.98M | --14.83M | 433.36%226.14M | --42.4M |
Acquisition of subsidiaries | ---- | ---- | 158.48%366.76M | ---- | 78.10%373.82M | 69.78%-627.16M | --209.89M | -98.52%-2.08B | ---1.05B |
Recovery of cash from investments | -18.25%71.22B | 3.63%58.93B | 17.67%115.98B | --87.12B | 12.49%56.87B | -18.94%98.56B | --50.55B | -14.27%121.59B | --141.82B |
Cash on investment | -31.99%-160.02B | 8.01%-78.16B | -35.92%-146.99B | ---121.24B | -47.61%-84.96B | -2.70%-108.15B | ---57.56B | 40.38%-105.3B | ---176.62B |
Other items in the investment business | -177.22%-223.18M | ---- | ---- | --289M | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | -169.47%-90.56B | 23.70%-20.64B | -131.10%-31.22B | ---33.61B | -312.12%-27.05B | -199.34%-13.51B | ---6.56B | 138.51%13.6B | ---35.31B |
Net cash before financing | -371.05%-30.3B | 369.42%12.85B | 26.17%26.68B | --11.18B | -81.54%2.74B | -56.88%21.15B | --14.83B | 1,144.47%49.05B | ---4.7B |
Cash flow from financing activities | |||||||||
New borrowing | 29.27%29.43B | 35.62%19.41B | -36.44%33.89B | --22.76B | -37.43%14.31B | 180.14%53.32B | --22.87B | -63.45%19.03B | --52.07B |
Refund | -8.98%-19.83B | -405.81%-19.08B | 26.28%-33.11B | ---18.19B | 3.67%-3.77B | -85.43%-44.92B | ---3.92B | 38.44%-24.23B | ---39.35B |
Interest paid - financing | ---- | 8.30%-805.92M | -18.97%-2.12B | ---- | -13.56%-878.83M | -27.31%-1.78B | ---773.88M | -10.65%-1.4B | ---1.27B |
Dividends paid - financing | -17.41%-22.3B | -20.68%-20.86B | -46.55%-17.52B | ---18.99B | -46.97%-17.29B | -4.03%-11.96B | ---11.76B | 0.55%-11.49B | ---11.56B |
Absorb investment income | 1,450.74%34.07B | ---- | ---- | --2.2B | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---5.22M | ---30.88M | ---- | ---- | ---- | ---1.26B | ---- | ---2.93B |
Other items of the financing business | -18.47%-1.4B | -42.69%1.1B | 158.94%2.54B | ---1.19B | 61.80%1.92B | 64.50%-4.32B | --1.19B | -631.97%-12.16B | --2.29B |
Net cash from financing operations | 248.85%19.96B | -225.84%-20.98B | -65.00%-17.91B | ---13.41B | -211.32%-6.44B | 65.61%-10.85B | --5.78B | -1,640.09%-31.56B | ---1.81B |
Effect of rate | -240.80%-239.9M | -303.47%-262.01M | -105.98%-17.25M | --170.39M | -11.67%128.77M | 159.46%288.49M | --145.79M | -26.55%-485.22M | ---383.41M |
Net Cash | -363.47%-10.34B | -119.59%-8.12B | -14.78%8.77B | ---2.23B | -117.95%-3.7B | -41.14%10.29B | --20.61B | 368.62%17.49B | ---6.51B |
Begining period cash | 17.12%59.89B | 17.12%59.89B | 26.10%51.13B | --51.13B | 26.10%51.13B | 72.20%40.55B | --40.55B | -22.64%23.55B | --30.44B |
Cash at the end | 0.48%49.31B | 8.28%51.5B | 17.12%59.89B | --49.07B | -22.43%47.56B | 26.10%51.13B | --61.31B | 72.20%40.55B | --23.55B |
Cash balance analysis | |||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | IAS | CAS (2007) | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | -- | PricewaterhouseCoopers | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data